Essential tremor. Treatment options

CNS Drugs

Volumn 6, Issue 3, 1996, Pages 178-191

  Ondo, William ^a   Jankovic, Joseph ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; ACETAZOLAMIDE; ALCOHOL; AROTINOLOL; ATENOLOL; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BOTULINUM TOXIN; CALCIUM ANTAGONIST; CLONAZEPAM; CLOZAPINE; FLUNARIZINE; GABAPENTIN; LIDOCAINE; METHAZOLAMIDE; METOPROLOL; NICARDIPINE; NIFEDIPINE; NIMODIPINE; PHENOBARBITAL; PRIMIDONE; PROPRANOLOL; SOTALOL; SPIRENDOLOL; THEOPHYLLINE;

BLOOD BRAIN BARRIER; HUMAN; PRIORITY JOURNAL; REVIEW; TREMOR;

EID: 0029793268     PISSN: 11727047     EISSN: None     Source Type: Journal    
DOI: 10.2165/00023210-199606030-00002     Document Type: Review

References (158)

1. Lou JS, Jankovic J. Essential tremor: clinical correlates in 350 patients. Neurology 1991; 41: 234-8
2. Findley L. Tremors: differential diagnosis and pharmacology. In: Jankovic J, Tolosa E, editors. Parkinson's diseuse and movement disorders. Baltimore: Williams and Wilkins, 1993: 293-313
3. Elble RJ, Higgins C, Leffler K, et al. Factors influencing the amplitude and frequency of essential tremor. Mov Disord 1994; 9: 589-96
4. Elble RJ, Higgins C, Hughes L. Longitudinal study of essential tremor. Neurology 1992; 42: 441-3
5. Hubble JP, Busenbark KL, Koller WC. Essential tremor. Clin Neuropharmacol 1989; 12: 453-82
6. Koller WC, Glatt S, Biary N, et al. Essential tremor variants: effect of treatment. Clin Neuropharmacol 1987; 10: 342-50
7. Marsden CD, Obeso J, Rothwell JC. Benign essential tremor is not a single entity. In: Yahr MD, edilor. Current concepts in Parkinson's disease. Amsterdam: Excerpta Medica, 1983: 31-46
8. Hallet M, Dubinsky R. Glucose metabolism in the brain of patients with essential tremor. J Neurol Sci 1993; 114: 45-8
9. Jenkins IH, Bain PG, Colebatch PD, et al. A positron emission tomography study of essential tremor: evidence for overactivity of cerebellar connections. Ann Neurol 1993; 34: 82-90
10. Koller WC, Findley L. Tremor rating scale. In: Findley L, Koller WC, editors. Handbook of tremor disorders. New York: Mareel Dekker, 1995: 1-5
11. Stiles RN. Mechanical and neural feedback in postural hand tremor of normal subjects. J Neurophysiol 1980; 44: 40-59
12. Van Hilten JJ, van Dijk JG. Dunnewold RJW, et al. Diurnal variation of essential and physiologic tremor. J Neurol Neurosurg Psychiatry 1991; 54: 516-9
13. Bain PG, Findley LJ, Atchison P, et al. Assessing tremor severity. J Neurol Neurosurg Psychiatry 1993; 56: 868-73
14. Bain PG, Mally J, Gresty M, et al. Assessing the impact of essential tremor on upper limb function. J Neurol 1993; 241: 54-61
15. Koller WC, Biary N. Effect of alcohol on tremor: comparison with propranolol. Neurology 1984; 34: 221-2
16. Findley L. The pharmacologic management of essential tremor. Clin Neuropharmacol 1986; 9 Suppl. 2: 61S-75S
17. Growdon JH, Shahani BT, Young RR. The effect of alcohol on essential tremor. Neurology 1975; 25: 259-62
18. Guan XM, Peroutka S. Basic mechanisms of action of drugs used in the treatment of essential tremor. Clin Neuropharmacol 1990; 13: 210-23
19. Ticku MK. Ethanol and the benzodiazepine-GABA receptor complex. Experientia 1989; 45: 413-8
20. Allen AM, Harris RA. Acute and chronic ethanol treatments alter GABA receptor operated chloride channels. Pharmacol Biochem Behav 1987; 27: 665-70
21. Llinas R, Yarom Y. Specific blockade of low threshold calcium channels by high molecular weight alcohols [abstract]. Soc Neurosci Abstr 1986; 12: 174
22. Sinton CM, Krosser BI, Walton KD, et al. The effectiveness of different isomers of alcohol as blockers of harmaline-induced tremor. Pflugers Arch 1989; 414: 31-6
23. Teraväinen H, Huttunen J, Lewitt P. Ineffective treatment of essential tremor with an alcohol methylpentynol. J Neurol Neurosurg Psychiatry 1986; 49: 198-9
24. Schroeder D, Nasrallah HA. High alcoholism rale in patients with essential tremor. Am J Psychiatry 1982; 139; 1471-3
25. Massey EW, Paulson GW. Cause and effecl in 'alcohol tremor' [letter]. Am J Psychol 1978; 135: 1572
26. Koller WC. Alcoholism in essential tremor. Neurology 1983; 33: 1074-6
27. Marshall J. Tremor. In: Vinken PJ, Bruyn GW, editors. Handbook of clinical neurology. Amsterdam. North Holland Publishing Company, 1968: 809-25
28. Sevitt I. The effect of adrenergic beta-receptor blocking drugs on tremor. Practioner 1970; 207: 677-8
29. Winkler GF, Young RR. The control of essential tremor by propranolol. Trans Am Neurol Assoc 1971; 96: 66-8
30. Dupont E, Hansen HJ, Dalby MA. Treatment of benign essential tremor with propranolol. Acta Neurol Scand 1973; 49: 75-84
31. Gilligan BS, Veale JL, Wodak J. Propranolol in the treatment of essential tremor: preliminary results. Med J Aust 1972; 1: 320-2
32. McClure CG, Davis JN. The effect of D-propranolol on action tremors. Trans Am Neurol Assoc 1976; 101: 269-70
33. Murray TJ. Treatment of essential tremor with propranolol. Can Med Assoc J 1972; 107: 984-6
34. Pakkenberg H. Propranolol in essential tremor [letter]. Lancet 1972; 1: 633
35. Teraväinen H, Fugelholm R, Larsen A. Effect of propranolol in essential tremor. Neurology 1976; 26: 27-30
36. Tolosa ES, Loewenson RB. Essential tremor: treatment with propranolol. Neurology 1975; 25: 1041-4
37. Winkler GF, Young RR. Efficacy of chronic propranolol therapy in action tremors of the familial, senile or essential varieties. N Engl J Med 1974; 290: 984-8
38. Jefferson D, Jenner P, Marsden CD. Beta-adrenoreceptor antagonists in essential tremor. J Neurol Neurosurg Psychiatry 1979; 42: 904-9
39. Cleeves LA, Findley LJ. Beta-adrenoreceptor mechanisms in essential tremor: a comparative single dose study of the effect of a non-selective and a beta-2 selective adrenoreceptor antagonist. J Neurol Neurosurg Psychiatry 1984; 47: 976-82
40. Kuroda Y, Kaligi R, Shibasaki H. Treatment of essential tremor with arotinolol. Neurology 1988; 38: 650-2
41. Young RR, Growdon JH, Shahani BT. Beta adrenergic mechanisms in action tremor. N Engl J Med 1975; 293: 950-3
42. Calzetti S, Findley LF, Gresty MA, et al. Effect of a single dose of propranolol in essential tremor: a double-blind controlled study. Ann Neurol 1983; 13: 165-71
43. Koller WC, Royce V. Time course of a single dose of propranolol in essential tremor. Arch Neurol 1986; 35: 1494-9
44. Abila B, Wilson JF, Marshall RW, et al. The tremorlytic action of beta-blockers in essential tremor, physiological and isoprenaline-induced tremor is mediated by beta-adrenoreceptors located deep in a peripheral component. Br J Clin Pharmacol 1985; 20: 369-76
45. Miyoshi T, Kennedy WR, Yoon KS. Morphometric comparisons of capillaries in muscle spindles, nerve and muscle. Arch Neurol 1979; 36: 547-52
46. Paul V. The role of adrenergic mechanisms in tremorine-induced tremors in rats: antitremor effects of beta-adrenoreceptor antagonists. Indian J Physiol Pharmacol 1986; 30: 307-12
47. Larsen TA, Teraväinen H. Beta-blockers in essential tremor [letter]. Lancet 1981; II: 533
48. Abila B, Marshall RW, Wilson JF, et al. Do beta-adrenoreceptor blockers have peripheral or central effects in essential tremor [abstract]? Br J Clin Pharmacol 1983; 16: 210P
49. Koller WC, Biarry N. Metoprolol compared to propranolol in treatment of essential tremor. Arch Neurol 1984; 41: 171-2
50. Newman RP, Jacobs L. Metoprolol in essential tremor. Arch Neurol 1980; 37: 596-7
51. Turnbull DM, Shaw DA. Metoprolol in essential tremor [letter]. Lancet 1980; I: 95
52. Riley T, Pleet AB. Metoprolol tartrate for essential tremor [letter]. N Engl J Med 1979; 301: 663
53. Ljung O. Treatment of essential tremor with metoprolol [letter]. N Engl J Med 1979; 301: 1005
54. Larsen TA, Teraväinen H. Beta-1 versus nonselective blockade in therapy of essential tremor. Adv Neurol 1983; 37: 247-51
55. Calzetti S, Findley LJ, Gresty MA, et al. Metoprolol and propranolol in essential tremor: a double-blind, controlled study. J Neurol Neurosurg Psychiatry 1981; 44: 814-9
56. Gengo FM, Ulatowski JA, McHugh WB. Metoprolol and alpha-hydroxymetoprolol concentrations and reduction in essential tremor. Clin Pharmacol Ther 1984; 36: 320-5
57. Leigh PN, Marsden CD, Twomey A, et al. Beta adrenoreceptor antagonists and essential tremor [letter]. Lancet 1981; I: 1032
58. Jefferson D, Wharrad HJ, Birmingham AT, et al. The comparative effects of ICI 118-551 and propranolol in essential tremor. Br J Clin Pharmacol 1987; 24: 729-34
59. Rinne UK, Kaitaniemi P. Sotalol in the treatment of essential tremor. In: Snart AG, editor. Advances in beta-adrenergic blocking therapy-sotalol. International Congress series 341. Amsterdam: Excerpta Medica, 1974: V56-61
60. Rangel-Guerra R. Treatment of benign essential tremor with a beta-adrenergic blocking agent-sotalol. In: Snart AG, editor. Advances in beta-adrenergic blocking therapy-sotalol. International Congress series 341. Amsterdam: Excerpta Medica, 1974: V62-66
61. Ogawa N, Takayama H, Yamamoto M. Comparative studies on the effectiveness of beta-adrenergic blockers in essential tremor. J Neurol 1987; 235: 31-3
62. Calzetti S, Findley LJ. D,L-propranolol and D-propranolol in essential tremor. In: Findley LJ, Capildeo R, editors. Movement disorders: tremor. London: Macmillan, 1984: 261-9
63. Teravainen H, Larsen A, Fogelholm R. Comparison between the effects of pindolol and propranolol on essential tremor. Neurology 1977; 27: 439-42
64. Sevitt I. A comparison of propranolol and benzhexol in essential tremor. Practitioner 1974; 213: 91-6
65. Koller WC. Nadolol in essential tremor. Neurology 1983; 33: 1076-7
66. Calzetti S, Perucca E. The pharmacological management of essential tremor. In: Findley L, Koller WC, editors. Handbook of tremor disorders. New York: Marcel Dekker, 1995: 263-74
67. Sabra AF, Hallet M. Action tremor with alternative activity in antagonist muscles. Neurology 1984; 32: 151-6
68. Calzetti S, Findley LJ, Gresty MA, et al. Effect of a single oral dose of propranolol on essential tremor: a double-blind controlled study. Ann Neurol 1983; 13: 165-71
69. Biary N, Koller WC. Essential tongue tremor. Mov Disord 1987; 2: 25-9
70. Koller WC. Propranolol therapy for essential tremor of the head. Neurology 1984; 34: 1077-9
71. Koller WC, Graner D, Mlcoch A. Essential voice tremor: treatment with propranolol. Neurology 1984; 35: 106-8
72. Koller WC. Dose-response relationship of propranolol in the treatment of essential tremor. Arch Neurol 1986; 43: 42-3
73. Koller WC, Biary N, Cone S. Disability in essential tremor: effect of treatment. Neurology 1986; 36: 1001-4
74. Sorenson PS, Paulson OB, Steiness E, et al. Essential tremor treated with propranolol: lack of correlation between clinical effect and plasma propranolol levels. Ann Neurol 1981; 9: 53-7
75. Koller WC. Long-acting propranolol in essential tremor. Neurology 1985; 35: 108-10
76. Cleeves L, Findley L. Propranolol and propranolol-LA in essential tremor: a double-blind comparative study. J Neurology Neurosurg Psychiatry 1988; 51: 379-84
77. Murray TJ. Long-term therapy of essential tremor with propranolol. Can Med Assoc J 1976; 115: 892-4
78. Koller WC, Vetere-Overfield B. Acute and chronic effects of propranolol and primidone in essential tremor. Neurology 1989; 39: 1587-8
79. Calzetti S, Sasso E, Baratti M, et al. Clinical and computer-based assessment of long-term therapeutic efficacy of propranolol in essential tremor. Acta Neurol Scand 1990; 81: 392-6
80. Elble RJ, Koller WC, editors. Tremor. Baltimore: Johns Hopkins University Press, 1990: 90-105
81. Panfilov V, Wahlqvist I, Olsson G. Use of beta-adrenoreceptor blockers in patients with congestive heart failure. Cardiovasc Drugs Ther 1995; 9: 273-87
82. Sackner B, Bernstein JD, Mancini DM. Rationale for treatment of patients with chronic heart failure with adrenergic blockade. JAMA 1995; 274: 1462-7
83. O'Brien MD, Upton AR, Toseland PA. Benign familial tremor treated with primidone. BMJ 1981; 282: 178-80
84. Chakrabarti A, Pearce JMS. Essential tremor: response to primidone [letter]. J Neurol Neurosurg Psychiatry 1981; 44: 650
85. Findley LJ, Calzetti S. Double-blind controlled study of primidone in essential tremor: preliminary results. BMJ 1982; 285: 608-9
86. Findley LJ, Calzetti S, Cleeves L. Primidone in essential tremor of the hands and head: a double-blind controlled clinical study. J Ncurol Neurosurg Psychiatry 1985; 48: 911-5
87. Gorman WP, Cooper R, Pocock P, et al. A comparison of primidone, propranolol, and placebo in essential tremor, using quantitative analysis. J Neurol Neurosurg Psychiatry 1986; 49: 64-8
88. Koller WC, Royse VL. Efficacy of primidone in essential tremor. Neurology 1986; 36: 121-4
89. Seyfert S, Hone A, Hall G. Primidone and essential tremor. J Neurol Neurosurg Psychiatry 1988; 235: 168-70
90. Dietrichson P, Espen E. Primidone and propranolol in essential tremor: a study based on quantitative tremor recording and plasma anticonvulsant levels. Acta Neurol Scand 1987; 75: 332-40
91. Sasso E, Perucca E, Fava R, et al. Primidone in the long term treatment of essential tremor: a prospective study with computerised quantitative analysis. Clin Neuropharmacol 1990; 13: 67-76
92. Sasso E, Perucca E, Negrotti A, et al. Acute tolerance to the tremorlytic effect of primidone. Neurology 1991; 41: 602-3
93. Shade H, Fahn S. Response of essential tremor to treatment with primidone [abstract]. Neurology 1987; 37 Suppl. 1: 122
94. Macdonald RL, McLean MJ. Anticonvulsant drugs: mechanisms of action. Adv Neurol 1986; 44: 713-36
95. Gallagher BB, Baumel IP, Mattson RH. Metabolic disposition of primidone and its metabolites in epileptic subjects after single and repeated administrations. Neurology 1972; 22: 1186-92
96. Calzetti S, Findley LJ, Pisani F, et al. Phenylethylmalonamide in essential tremor: a double-blind controlled study. J Neurol Neurosurg Psychiatry 1981; 44: 932-4
97. Baruzzi A, Procacianti G, Martineli P, et al. Phenobarbital and propranolol in essential tremor: a double-blind controlled clinical trial. Neurology 1983; 33: 296-300
98. Findley LJ, Cleeves L. Phenobarbital in essential tremor. Neurology 1985; 35: 1784-7
99. Sasso E, Perucca E, Calzetti S. Double-blind comparison of primidone and phenobarbital in essential tremor. Neurology 1988; 38: 808-10
100. Sasso U, Perucca E, Fava R, et al. Quantitative comparison of barbiturates in essential hand and head tremor. Mov Disorders 1991; 6: 65-8
101. Thompson C, Lang A, Parkes JD, et al. A double-blind trial of clonazepam in essential benign tremor. Clin Neuropharmacol 1984; 7: 83-8
102. Biary N, Koller WC. Kinetic predominant essential tremor: successful treatment with clonazepam. Neurology 1987; 37: 471-4
103. Heilman KM. Orthostatic tremor. Arch Neurol 1984; 41: 880-1
104. Huber SJ, Paulson GW. Efficacy of alprazolam for essential tremor. Neurology 1988; 38: 241-3
105. Ince D, Aklan S. New therapeutic alternatives for essential tremor: alprazolam and acetazolamide [abstract]. Mov Disord 1994; 9 Suppl. 1: 23
106. Koller WC, Rubino F, Gupta S. Pharmacologic probe with progabide of GABA mechanism in essential tremor. Arch Neurol 1987; 44: 905-6
107. Mondrup K, Dupont E, Pedersen E. The effect of the GABA agonist, progabide, on benign essential tremor: a controlled clinical trial. Acta Neurol Scand 1983; 68: 248-52
108. Topaktas S, Onur R, Dalkara T. Calcium channel blockers and essential tremor. Eur Neurol 1987; 27: 114-9
109. Biary N, Al Deeb S, Langenberg P. The effect of flunarizine on essential tremor. Neurology 1991; 41: 311-2
110. Curran T, Lang A. Flunarizine in essential tremor. Clin Neuropharmacol 1993; 16: 460-3
111. Garcia-Ruiz PJ, Garcia de Yebenes J, Jimenez-Jimenez FJ, et al. Parkinsonism associated with calcium channel blockers: a prospective follow-up study. Clin Neuropharmacol 1992; 15: 19-26
112. Garcia-Ruiz PJ, Garcia de Yebenes Prous J, Jimenez-Jimenez J. Eftect of nicardipine on essential tremor: brief report. Clin Neuropharmacol 1993; 16: 456-9
113. Jimenez-Jimenez J, Garcia-Ruiz PJ, Cabrera-Valdivia F. Nicardipine versus propranolol in essential tremor. Acra Neurol 1994; 16: 184-8
114. Biary N, Bahou Y, Sofi MA, et al. The effect of nimodipine on essential tremor. Neurology 1995; 45: 1523-5
115. Muenter MD, Daube JR, Caviness JN, et al. Treatment of essential tremor with methazolamide. Mayo Clin Proc 1991; 66: 991-7
116. Busenbark K, Pahwa R, Hubble J, et al. Double-blind controlled study of methazolamide in the treatment of essential tremor. Neurology 1993; 43: 1045-7
117. Busenbark K, Pahwa R, Hubble J, et al. The effect of acetazolamide on essential tremor: an open label trial. Neurology 1992; 42: 1394-5
118. Burrows GT, King RB. Gabapentin in essential tremor. Neurology 1995; 45 Suppl. 4. A187-8
119. Mally J, Stone T. The effect of theophylline on essential tremor: the possible role of GABA. Pharmacol Biochem Behav 1991; 39: 345-9
120. Mally J. Comparative study of theophylline and propranolol in essential tremor [in Hungarian]. Orv Hetil 1992; 133: 981-3
121. Buss D, Phillis I, Littly M, et al. The effect of theophylline on thyrotoxic tremor. Br J Clin Pharmacol 1989; 28: 103-7
122. Pakkenberg H, Pakkenberg B. Clozapine in the treatment of tremor. Acta Neurol Scand 1986; 73: 295-7
123. McCarthy R. Clozapine reduces essential tremor independent of its antipsychotic effect: a case report. J Clin Psychopharmacol 1994; 14: 212-3
124. Korsgaard C, Regeur L. Werdelin L. Clozapine in the treatment of tremor - clinical experience since 1986 [abstract]. Mov Disord 1994; 9 Suppl. 1: 20
125. McLeod NA, White LE. Trazodone in essential tremor. JAMA 1986; 256: 2675-6
126. Sanson F, Schergna E, Semenzato D, et al. Therapeutic effect of trazodone in the treatment of tremor: multicentric double-blind study. Riv Neurol 1986; 56: 358-64
127. Cleeves L, Findley LJ. Trazodone is ineffective in essential tremor. J Neurol Neurosurg Psychiatry 1990; 53: 268-9
128. Mai J, Olsen RB. Depression of essential tremor by alpha-adrenergic blockade [letter]. J Neurol Neurosurg Psychiatry 1981; 44: 1171
129. Koller WC. Ineffectiveness of phenoxybenzamine in essential tremor [letler]. J Neurol Neurosurg Psychiatry 1986; 49: 222
130. Caccia MR, Osio M, Galimberti V, et al. Propranolol, clonidine, urapidil and trazodone infusion in essential tremor: a double-blind cross-over trial. Ada Neurol Scand 1989; 79: 379-83
131. Koller WC, Herbster G, Cone S. Clonidine in the treatment of essential tremor. Mov Disord 1986; 1: 235-7
132. Caccia MR, Mangoni A. Clonidine in essential tremor: preliminary observations from an open trial. J Neurology 1985; 232: 55-7
133. Ishizaki F, Harada T, Kito S, et al. The effect of bovine brain ganglioside on essential tremor. Hiroshima J Med Sci 1991; 40: 83-5
134. National Institutes of Health Consensus Development Conference. Clinical use of botulinum toxin. Arch Neurol 1991; 48: 1294-8
135. Jankovic J, Brin MF. Therapeutic uses of botulinum toxin. N Engl J Med 1991; 324: 1186-94
136. Coffield J, Considine R, Simpson L. The site and mechanism of action of botulinum neurotoxin. In: Jankovie J, Hallett M, editors. Therapy with botulinum toxin. New York: Marcel Dekker, 1994: 3-15
137. Jankovic J, Schwartz K. Botulinum toxin treatment of tremors. Neurology 1991; 41: 1185-8
138. Trosch RM, Pullman SL. Botulinum toxin A injections for the treatment of hand tremors. Mov Disord 1994; 9: 601-9
139. Jankovic J, Schwartz K, Clemence W, et al. A randomized, double-blind, placebo controlled study to evaluate botulinum toxin type A in essential hand tremor. Mov Disord 1996; 11: 250-6
140. Pahwa R, Busenbark K, Swanson-Hyland MA, et al. Botulinum toxin treatment of essential head tremor. Neurology 1995; 45: 822-4
141. Rondot P, Korn H, Scherrer J. Suppression of an entire limb tremor by anesthetizing a selective muscular group. Arch Neurol 1968; 19: 421-9
142. Kaji R, Rothwell J, Katayama M, et al. Tonic vibration reflex and muscle afferent block in writers cramp. Ann Neurol 1995; 38: 155-62
143. Pozos RS, Iaizzo PA. Effects of topical anesthesia on essential tremor. Electromyogr Clin Neurophysiol 1992; 32: 369-72
144. Koller W. Treatment of tremor disorders. In: Kurlan R, editor. Treatment of movement disorders. Philadelphia: J.B. Lippincott Company, 1995: 422-3
145. Andrew J. Surgical treatment of tremor. In: Findley LJ, Capildeo R, editors. Movement disorder: tremor. London: Macmillan, 1984: 339
146. Matsumoto K, Shichijo F, Fukami T. Long term follow up review of Parkinson's disease after unilateral or bilateral thalamotomy. J Neurosurg 1984; 60: 1033-44
147. Fox MW, Ahlskog JE, Kelly PJ. Stereotactic ventrolateralis thalamotomy for medically refractory tremor in post-levodopa era Parkinson's disease patients. J Neurosurg 1992; 75: 723-30
148. Goldman MS, Ahlskog JE, Kelly PJ. The symptomatic and functional outcome of stereotactic thalamotomy for medically intractable essential tremor. J Neurosurg 1992; 76: 924-8
149. Jankovic J, Cardosa F, Grossman R, et al. Outcome after stereotactic thalamotomy for parkinsonian, essential, and other types of tremor. Neurosurgery 1995; 37: 680-7
150. Rand RW, Jacques DB, Melbye RWb et al. Gamma knife thalamotomy and pallidotomy in patients with movement disorders: preliminary results. Stereotact Fund Neurosurg 1993; 61 Suppl. 1: 65-92
151. Busenbark K, Wilkinson S, Lyons K, et al. Quality of life in thalamic stimulation for tremor as measured by the sickness impact profile [abstract]. Neurology 1996; 46: A372
152. Benabid AL, Pollak P, Gervason C, et al. Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus. Lancet 1991; 337: 403-6
153. Benabid AL, Pollak P, Seigneuret E, et al. Chronic VIM thalamic stimulation in Parkinson's disease, essential tremor and extra-pyramidal dyskinesias. Acta Neurochir 1993; 58 Suppl.: 39-44
154. Blond S, Caparros-Lefebvre D, Parker F, et al. Control of tremor and involuntary movement disorders by chronic stereotactic stimulation of the ventral intermediate thalamic nucleus. J Neurosurg 1992; 77: 62-8
155. Benabid AL, Pollak P, Gao D, et al. Chronic electrical stimulation of the ventralis intermedious nucleus of the thalamus as a treatment of movement disorders. J Neurosurg 1996; 84: 203-14
156. Caparros-Lefebvre D, Ruchoux MM, Blond S, et al. Long tern thalamic stimulation in Parkinson's disease: postmortem anatomoclinical study. Neurology 1994; 44: 1856-60
157. Hubble JP, Busenbark KL, Wilkinson S. Deep brain stimulation for essential tremor. Neurology. In press
158. Villagra F, Lyons K, Koller W, et al. Lack of rebound effect on tremor in Parkinson's disease and essential tremor patients that have undergone VIM thalamic stimulation [abstract]. Neurology 1996; 46: A372